SlateStone Wealth’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
Other funds holding NAGE
SlateStone Wealth's NAGE Position: Q3 2026 in Review
SlateStone Wealth opened a new position in Niagen Bioscience (NAGE) in Q3 2026: 10,000 shares worth $29.2K. The stake represents ﹤0.01% of the portfolio and ranks #281 among its holdings.
123 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.
- SlateStone Wealth held 10,000 shares of Niagen Bioscience worth $29.2K as of Q3 2026.
- Niagen Bioscience was a new SlateStone Wealth position in Q3 2026.
- Niagen Bioscience made up ﹤0.01% of SlateStone Wealth's portfolio in Q3 2026, its #281 holding.
- 123 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.
Based on SlateStone Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.